The pharmacokinetics and safety of porfimer after repeated administration 30-45 days apart to patients undergoing photodynamic therapy

Pereira, S P; Ayaru, L; Ackroyd, R; Mitton, D; Fullarton, G; Zammit, M; Grzebieniak, Z; Messmann, H; Ortner, M-A; Gao, L; Trinh, M M; Spénard, J (2010). The pharmacokinetics and safety of porfimer after repeated administration 30-45 days apart to patients undergoing photodynamic therapy. Alimentary pharmacology & therapeutics, 32(6), pp. 821-7. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04400.x

Full text not available from this repository. (Request a copy)

Porfimer is an intravenous (i.v.) injectable photosensitizing agent used in the photodynamic treatment of tumours and of high-grade dysplasia in Barrett's oesophagus.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology

UniBE Contributor:

Ortner, Marianne

ISSN:

0269-2813

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:10

Last Modified:

04 May 2014 23:05

Publisher DOI:

10.1111/j.1365-2036.2010.04400.x

PubMed ID:

20629974

Web of Science ID:

000280972200013

URI:

https://boris.unibe.ch/id/eprint/1486 (FactScience: 203168)

Actions (login required)

Edit item Edit item
Provide Feedback